Opportunity
DIBBS #SPE2DP-26-T-2954
DLA Solicitation for Ceftriaxone Injection, 1g, 3 Packages (25 Vials Each) for Fort Bragg
Posted
April 20, 2026
Respond By
April 27, 2026
Identifier
SPE2DP-26-T-2954
NAICS
424210
This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA seeking Ceftriaxone Injection for military medical supply: - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - Contracting office: DLA Troop Support, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - HIKMA PHARMACEUTICALS USA INC. - SAGENT PHARMACEUTICALS, INC - WG CRITICAL CARE, LLC - Products Requested: - Ceftriaxone Injection, USP, 1 gram strength - NSN: 6505-01-554-4282 - Packaged as 25 single-use vials per package - Quantity: 3 packages (total 75 vials) - Approved part numbers: - HIKMA: NDC00143-9857-25 - SAGENT: NDC25021-0106-10 - WG CRITICAL CARE: NDC44567-0701-25 - Notable Requirements: - Strict compliance with domestic sourcing laws - Hazardous material labeling per Medical Marking Standard No. 1A - Cybersecurity requirements apply - Minimum 21 months shelf life remaining at receipt - Storage at 20 to 25°C, protected from light - Delivery Location: - Fort Bragg, NC (5234 Eagle Talon Dr Bldg X3063) - Period of Performance: - Delivery required within 20 days of award - Opportunity Type: - Fast award, open for responses
Description
CEFTRIAXONE INJECTI (QTY: 3, NSN: 6505-01-554-4282, Purchase Request: 7016388817) Approved Sources: - CAGE: 32655, Part No: NDC00143-9857-25, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 4RP13, Part No: NDC25021-0106-10, Company: SAGENT PHARMACEUTICALS, INC - CAGE: 6XJQ8, Part No: NDC44567-0701-25, Company: WG CRITICAL CARE, LLC